Singapore stocks ended Monday (Jul 17) with a gain of 0.2 per cent or 5.8 points at 3,254.43. DBS was the top advancer by value. The counter rose 1.5 per cent or S$0.48 to S$32.47. Another in the banking trio, OCBC, too was among the top gainers for the day. Its shares added 0.7 per cent or S$0.08 to S$12.45. UOB, however, was among the biggest losers for the day, with its shares falling 0.4 per cent or S$0.12 to S$27.71. Jardine Cycle and Carriage was the top decliner, falling 1.1 per cent or S$0.39 to S$34.20. Venture Corporation was another notable decliner, losing 0.9 per cent or S$0.14 to S$15.04. Seatrium was the most actively traded counter by volume for the day, with about 439.9 million shares traded. The counter lost 2.8 per cent or S$0.004 to close at S$0.141.

Wall Street stocks rose Monday (Jul 17), extending a market rally ahead of major earnings reports and economic releases this week. The Dow Jones Industrial Average finished up 0.2 per cent at 34,585.35. The broad-based S&P 500 added 0.4 per cent at 4,522.79, while the tech-rich Nasdaq Composite Index jumped 0.9 per cent to 14,244.95.

Top gainers & losers





Singapore’s non-oil domestic exports (NODX) for June fell by 15.5% y-o-y, extending the 14.8% decrease in May. During the month, electronic and non-electronic exports declined. Electronic NODX fell by 15.9% on a y-o-y basis led by the declines of integrated circuits (ICs), personal computers (PCs) and parts of PCs which fell by 31.8%, 44.2% and 44.8% respectively. Non-electronic NODX fell by 15.4% y-o-y with petrochemicals, pharmaceuticals and primary chemicals contributing the most to the decline at 34.0%, 29.5% and 61.8% respectively. NODX to the top markets fell on the whole, although NODX to Hong Kong and China rose. The top contributors to the decline in NODX were Malaysia (-30.7%), Indonesia (-35.7%) and South Korea (-24.2%). On a m-o-m seasonally adjusted basis, NODX grew by 5.4% in June to $14.5 billion as electronic and non-electronic NODX increased.

Singapore Airlines (SIA) carried 2.9 million passengers on a group level in June, up 50.4 per cent from a year ago, it said in its operating results filed to the bourse on Monday (Jul 17). The group’s passenger load factor last month also hit a monthly record of 90.6 per cent, marking a 5.1 percentage point increase on a year-on-year basis. Both SIA and Scoot posted record passenger load factors of 89.7 per cent and 93.6 per cent for the month, respectively. Cargo operations registered a load factor of 51.6 per cent, down 13 percentage points year on year. Cargo loads declined by 14.9 per cent year on year due to weaker demand, said the group, while capacity expanded by 6.6 per cent as increased passenger services resulted in higher bellyhold capacity.

Thomson Medical Group has issued S$30 million worth of notes that mature in 2028 at 5.5 per cent interest. The notes will be consolidated with some S$120 million worth of existing notes due in 2028 – which were issued on May 31 – to form a single series. They are part of the group’s S$1 billion multi-currency debt-issuance programme. Interest is payable semi-annually in arrears. The notes will mature five years from May 31, 2023. Net proceeds from the issue of these notes will be used for general corporate purposes, Thomson Medical said.

TA Corporation’s wholly-owned subsidiary, Tiong Aik Construction, has been placed under provisional liquidation as it is unable to pay its debts, the group said in a bourse filing on Monday (Jul 17). TA Corporation noted that the board of directors of Tiong Aik Construction resolved to appoint provisional liquidators after assessing that its financial condition was such that it was “presently unable to pay its debts as and when they fall due”. TA Corporation has also requested voluntary suspension of the trading of its shares as a matter of “prudence”, pending engagement with its stakeholders and clarity on the financial position of the company, as well as the group.

The closing date for the offer to acquire and delist shipbuilder Penguin International has been extended for a third time to 5.30 pm on Aug 3, the company said on Monday (Jul 17). The offer, priced at S$0.83 a share, was originally set to close on Jun 22. This was extended to Jul 6, before being extended again to Jul 20. This is the offeror’s second attempt to take the company private, following an unsuccessful bid in 2021. As at 6 pm on Monday, the offeror and persons acting in concert have garnered 88.57 per cent of the total number of shares in the company.


Meta Platforms will be fined one million kroner (S$131,365) per day over privacy breaches unless it takes remedial action, Norway’s data protection authority said on Monday (Jul 17), in a move that could have wider European implications. Regulator Datatilsynet said it would charge the fine every day from Aug 4 until Nov 3, unless Meta takes action. It said Meta cannot harvest user data in Norway, such as users’ physical locations, and use it to target advertising at them. Meta said it would review Datatilsynet’s decision, and that there would be no immediate impact on its services. Datatilsynet has referred its move to the European Data Protection Board, which, if the latter agrees, could make the fine permanent and widen the decision’s territorial scope in Europe.

Microsoft said it has a binding agreement to keep the Call of Duty franchise on the Sony Playstation platform as its planned acquisition of Activision Blizzard appears closer to completion. The announcement on Sunday (Jul 16) of a deal with Sony Group from Microsoft seeks to address regulators’ concerns that the merger would make more Activision games – such as the massively popular shooting-game franchise – exclusive to Xbox. The deal is for 10 years, a Microsoft spokesperson said.

Ford deepened a price war in the electric-vehicle (EV) industry on Monday (Jul 17) by slashing the prices of its F-150 Lightning trucks, including a 17 per cent cut for the base model. The company said it was able to cut prices following improvements in scale and battery raw material costs. In the quarter through June, Ford’s EV sales fell 2.8 per cent. Battery raw material prices have been one of the factors that pushed EV prices up. But prices of cobalt and lithium, crucial for EV batteries, have declined. The base Pro variant of Lightning now carries a suggested retail price of US$49,995, compared with its prior price of US$59,974, while the higher-end Platinum model will cost about 6.2 per cent less, at US$91,995.

Bridgebio Pharma’s experimental drug for a rare heart disease showed significant improvement in patients in a late-stage study. The drug was 1.8 times better than placebo when measured for preventing death, hospitalisation and improvement in six minutes’ walking distance as part of the main goal, the company said. The drug, acoramidis, also helped improve survival by 81 per cent in patients on the treatment compared to 74 per cent on the placebo, and also reduced frequency of heart disease-related hospitalisation by 50 per cent. No safety concerns were identified, the company said. BridgeBio plans to submit the data to the US Food and Drug Administration (FDA) by the end of 2023, as part of its marketing application. The company also expects to file in additional markets next year.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Guest Presentation by Ohmyhome [NEW]

Date: 20 July 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/52fef7dh

POEMS Podcast:

Research Videos

Weekly Market Outlook: SG & US 3Q2023 Stock Picks, Technical Analysis & More…
Date: 17 July 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com